Okta (OKTA) is lower today as the market reacts to renewed analyst caution expressed through price-target reductions. Morgan Stanley cut its price target on Okta to $101 from $110 while reiterating an Overweight rating, noting that while recent results were broadly in line with buy-side expectations, the key catalyst for the stock is a clear commitment to growth reacceleration that remains unconfirmed.

The price-target trim keeps the core debate intact: Okta’s fundamentals are stable enough to keep bullish ratings in place at some firms, but investors want clearer evidence that demand and billings momentum are accelerating rather than merely holding steady. The latest note frames the near-term setup as “ingredients” for improvement—particularly as newer products gain traction—without a definitive timeline that would satisfy momentum-oriented investors.

Near-term trading focus is likely to stay on incremental channel checks and additional analyst resets, especially any commentary that tightens or loosens expectations for a reacceleration in growth. Investors are also watching the cadence of product adoption and whether management’s next set of updates can turn ‘potential’ into measurable leading indicators ahead of the next earnings report.